Atea Pharmaceuticals
AVIR
AVIR
129 hedge funds and large institutions have $190M invested in Atea Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 48 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 48
32% less capital invested
Capital invested by funds: $278M → $190M (-$88M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
129
Holding in Top 10
1
Calls
$187K
Puts
$48K
Top Buyers
| 1 | +$3.36M | |
| 2 | +$3.27M | |
| 3 | +$2.29M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$812K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$512K |
Top Sellers
| 1 | -$5.03M | |
| 2 | -$4.63M | |
| 3 | -$3.49M | |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$1.26M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
-$842K |